Mark Lawson
Director & Chair of the Audit Committee (Cybn - Nyse) @Helus Pharma
Signup · Get unlimited contacts
WORK HISTORY
Director & Chair of the Audit Committee (Cybn - Nyse) @Helus Pharma
A clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options. Deep governance & public company experience ensuring compliance, shareholder engagement, and maintenance of fiduciary responsibilities.• Providing financial oversight, governance expertise, and strategic counsel while navigating a complex regulatory environments.• Regulatory & Governance: Deep understanding of public company reporting, audit committee responsibilities, and corporate compliance.• Audit & Risk Oversight: Proficient in financial reporting, SOX compliance, and enterprise risk management (ERM).
EDUCATION
Western University
Master of Business Administration (MBA), Accounting and Finance
Western University
Bachelor of Arts (B.A.), Statistics
ABOUT MARK LAWSON
Mark is an experienced private equity and investment banking executive with 20 years of…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.